NYSE:LH - Laboratory Corp. of America Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$189.13 +1.55 (+0.83 %)
(As of 06/22/2018 04:00 PM ET)
Previous Close$187.58
Today's Range$187.44 - $189.63
52-Week Range$146.68 - $190.35
Volume661,100 shs
Average Volume700,745 shs
Market Capitalization$19.07 billion
P/E Ratio19.70
Dividend YieldN/A
Beta0.93
Laboratory Corp. of America logoLaboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates through two segments, LabCorp Diagnostics and Covance Drug Development. It offers a range of clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, prostate-specific antigen, tests for sexually-transmitted diseases, hepatitis C tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens. The company also provides specialty testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, medical drug monitoring, and pain management; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, it provides drug development solutions and laboratory testing services; and testing services through a sales force to the managed care organizations, biopharmaceutical companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, food and nutritional companies, and independent clinical laboratories. The company has collaboration with university, hospital and academic institutions, such as Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, and Yale University to license and commercialize new diagnostic tests. Laboratory Corporation of America Holdings was founded in 1971 and is headquartered in Burlington, North Carolina.

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
SymbolNYSE:LH
CUSIP50540R40
Phone336-229-1127

Debt

Debt-to-Equity Ratio0.91
Current Ratio1.38
Quick Ratio1.27

Price-To-Earnings

Trailing P/E Ratio19.70
Forward P/E Ratio16.36
P/E Growth1.64

Sales & Book Value

Annual Sales$10.44 billion
Price / Sales1.85
Cash Flow$15.1912 per share
Price / Cash12.45
Book Value$67.09 per share
Price / Book2.82

Profitability

EPS (Most Recent Fiscal Year)$9.60
Net Income$1.27 billion
Net Margins11.52%
Return on Equity16.33%
Return on Assets6.49%

Miscellaneous

Employees60,000
Outstanding Shares101,900,000

Laboratory Corp. of America (NYSE:LH) Frequently Asked Questions

What is Laboratory Corp. of America's stock symbol?

Laboratory Corp. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

How were Laboratory Corp. of America's earnings last quarter?

Laboratory Corp. of America Holdings (NYSE:LH) announced its quarterly earnings data on Wednesday, April, 25th. The medical research company reported $2.78 earnings per share for the quarter, topping analysts' consensus estimates of $2.63 by $0.15. The medical research company earned $2.85 billion during the quarter, compared to analyst estimates of $2.77 billion. Laboratory Corp. of America had a net margin of 11.52% and a return on equity of 16.33%. The firm's revenue for the quarter was up 18.0% on a year-over-year basis. During the same period in the previous year, the business earned $2.22 EPS. View Laboratory Corp. of America's Earnings History.

When is Laboratory Corp. of America's next earnings date?

Laboratory Corp. of America is scheduled to release their next quarterly earnings announcement on Tuesday, July, 24th 2018. View Earnings Estimates for Laboratory Corp. of America.

What guidance has Laboratory Corp. of America issued on next quarter's earnings?

Laboratory Corp. of America updated its FY18 earnings guidance on Wednesday, April, 25th. The company provided earnings per share guidance of $11.30-11.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $11.54.

What price target have analysts set for LH?

16 Wall Street analysts have issued 1 year price targets for Laboratory Corp. of America's stock. Their forecasts range from $172.00 to $220.00. On average, they anticipate Laboratory Corp. of America's stock price to reach $192.3125 in the next year. View Analyst Ratings for Laboratory Corp. of America.

Who are some of Laboratory Corp. of America's key competitors?

Who are Laboratory Corp. of America's key executives?

Laboratory Corp. of America's management team includes the folowing people:
  • Mr. David P. King, Chairman, CEO & Pres (Age 62)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 57)
  • Mr. Lance V. Berberian, Chief Information Officer & Sr. VP (Age 55)
  • Mr. F. Samuel Eberts III, Chief Legal Officer, Chief Compliance Officer, Sr. VP & Sec. (Age 58)
  • Ms. Lisa J. Uthgenannt, Chief HR Officer & Sr. VP (Age 57)

Has Laboratory Corp. of America been receiving favorable news coverage?

News stories about LH stock have trended somewhat positive recently, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Laboratory Corp. of America earned a news impact score of 0.09 on Accern's scale. They also assigned news stories about the medical research company an impact score of 45.86 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

Who are Laboratory Corp. of America's major shareholders?

Laboratory Corp. of America's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.83%), Boston Partners (5.57%), Iridian Asset Management LLC CT (1.66%), Dimensional Fund Advisors LP (1.40%), JPMorgan Chase & Co. (1.38%) and Northern Trust Corp (1.35%). Company insiders that own Laboratory Corp. of America stock include Adam H Schechter, David P King, Dwight Gary Gilliland, Edward T Dodson, F Samuel Eberts III, Glenn A Eisenberg, Jean-Luc Belingard, Lance Berberian, Lisa J Uthgenannt, M Huff Gary, R Sanders Williams and Robert E Mittelstaedt Jr. View Institutional Ownership Trends for Laboratory Corp. of America.

Which major investors are selling Laboratory Corp. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including Check Capital Management Inc. CA, State of New Jersey Common Pension Fund D, Millennium Management LLC, Global Thematic Partners LLC, Thompson Siegel & Walmsley LLC, Sentry Investments Corp., Swiss National Bank and Tamarack Advisers LP. Company insiders that have sold Laboratory Corp. of America company stock in the last year include Adam H Schechter, David P King, Dwight Gary Gilliland, Edward T Dodson, F Samuel Eberts III, Glenn A Eisenberg, Lisa J Uthgenannt, M Huff Gary and R Sanders Williams. View Insider Buying and Selling for Laboratory Corp. of America.

Which major investors are buying Laboratory Corp. of America stock?

LH stock was acquired by a variety of institutional investors in the last quarter, including Amundi Pioneer Asset Management Inc., Boston Partners, Rothschild Asset Management Inc., Royal Bank of Canada, Teacher Retirement System of Texas, Stevens Capital Management LP, Iridian Asset Management LLC CT and University of Notre Dame DU Lac. View Insider Buying and Selling for Laboratory Corp. of America.

How do I buy shares of Laboratory Corp. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Laboratory Corp. of America's stock price today?

One share of LH stock can currently be purchased for approximately $189.13.

How big of a company is Laboratory Corp. of America?

Laboratory Corp. of America has a market capitalization of $19.07 billion and generates $10.44 billion in revenue each year. The medical research company earns $1.27 billion in net income (profit) each year or $9.60 on an earnings per share basis. Laboratory Corp. of America employs 60,000 workers across the globe.

How can I contact Laboratory Corp. of America?

Laboratory Corp. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]


MarketBeat Community Rating for Laboratory Corp. of America (LH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  364 (Vote Outperform)
Underperform Votes:  401 (Vote Underperform)
Total Votes:  765
MarketBeat's community ratings are surveys of what our community members think about Laboratory Corp. of America and other stocks. Vote "Outperform" if you believe LH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.